| abstract |
Disclosure of the invention relates to compounds which are sodium channel inhibitors and their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In certain embodiments, the structure of the compound is represented by the formula (I) Wherein Y, Z, n, R < 1 > and R < 3 > are as defined herein. This disclosure also relates to methods of making such compounds and to pharmaceutical compositions containing such compounds. |